FBR sees huge upside for Novavax on RSV vaccine potential

Novavax (NVAX +8.3%) is up sharply in morning trading.

Helping the cause is FBR's William Tanner, who calls the company "one of the mos compelling small-cap vaccine plays in the biopharma sector by virtue of the vaccine for preventing RSV infection."

Although Tanner thinks absence of visibility into stockpiling plans makes it "difficult to ascribe much value" to NVAX's pandemic vaccine programs, he says that "if safe and effective, the [RSV] vaccine could have broad utility for preventing infection in pregnant women, neonates (by virtue of maternal vaccination), infants, and young children and the elderly."

Shares initiated at Outperform.

Price target is $11, representing upside of around 280% from Tuesday's close.

From other sites
Comments (3)
  • Shane Blackmon
    , contributor
    Comments (505) | Send Message
    On Aug 15th, same analyst initiated with same PT of $11/share... moved from Lazard to FBR... it's kind of old news.


    Good luck to all.
    30 Oct 2013, 11:18 AM Reply Like
  • theTalkativeOne
    , contributor
    Comments (89) | Send Message
    Thanks but Lazard was one and FBR makes two. That's 100% increase not to mentioned since Lazards call the stocks held firm. Old news?
    30 Oct 2013, 12:36 PM Reply Like
  • Shane Blackmon
    , contributor
    Comments (505) | Send Message
    I'm not sure you are understanding what i am saying...
    Everyone jumped ship from Lazard, the analyst at Lazard is the current analyst at FBR. It's the same person, making the same call at a different firm.


    He initiated on over a dozen names today, the same names he covered at Lazard.
    30 Oct 2013, 02:34 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs